• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Big Alcohol. Big Tobacco. What About Big Marijuana?

By Mark Collins | HCN Opinion When Democratic Texas U.S. Senate candidate James Talarico identified Big Alcohol and Big Tobacco as beneficiaries of restrictions on hemp-derived THC, he raised an important question: Who profits when ...

Curaleaf Refuses to Back Down

STAMFORD – One day after the Alberta Securities Commission (ASC) dismissed Curaleaf's application to shut down Aurora Cannabis's at-the-market (ATM) share issuance program, Curaleaf Holdings pushed back with a firm statement, insisting the ruling changes ...

Optimi Goes Down Under with New Australian Subsidiary

VANCOUVER / SYDNEY – Optimi Health Corp., a commercial-stage pharmaceutical developer and manufacturer of regulated psychedelic drug products, announced the establishment of Optimi Australia Pty Ltd, a wholly owned subsidiary responsible for distribution and business ...

Glass House Brands Triggers Warrant Acceleration

LONG BEACH – Glass House Brands Inc., a major player in California Cannabis production and retail, has told holders of warrants issued in two earlier financing rounds that their right to convert those securities into ...

Otsuka Completes $1.23B Buyout of Transcend Therapeutics

PRINCETON – Otsuka America, the U.S. subsidiary of Otsuka Pharmaceutical Co., Ltd., announced that it has completed its acquisition of Transcend Therapeutics, a New York biotechnology company developing rapid-acting treatments for neuropsychiatric disease. First disclosed ...

Glass House Brands Applies for NYSE Uplisting

LONG BEACH – Glass House Brands Inc., a vertically integrated Cannabis company concentrated in California, announced it has applied to list its subordinate voting shares on the New York Stock Exchange. The filing is among ...

Optimi Ships Psilocybin to the UK for Phase 2 Trial

VANCOUVER – Optimi Health Corp. announced it has completed its first export of naturally derived psilocybin to the United Kingdom, with the material earmarked for a planned Phase 2 clinical trial whose partner and therapeutic ...

Trulieve Announces Share Buyback Program

TALLAHASSEE – Trulieve Cannabis Corp. announced that its Board of Directors has authorized a share repurchase program, allowing the company to buy back up to the lesser of $50 million in aggregate value or 8,495,038 ...

Subscribe To Our Newsletter

Go to Top